Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

COBALT XT  ICDs and CRT-Ds

Cobalt™ XT ICDs and CRT-Ds are enabled with BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring. These devices include an automated ATP algorithm and are compatible with a simplified heart failure risk stratification tool. 

Download Brochure
Image showing Cobalt XT ICDs and CRT-Ds

Overview

the Future IS HERE

Meet Cobalt XT ICDs and CRT-Ds

Exclusive ATP algorithm, heart failure risk stratification, tablet-based programming and app-based remote monitoring, extended longevity, and 40 J on all shocks.

UNMATCHED FEATURE SUITE 

Extended Longevity

Real-world projections based on CareLink™ patient data. 

Graph depicting Cobalt XT's longevity projections against Claria and Amplia MRI devices
Graph depicting Cobalt XT's Dual Chamber's longevity projections against Evera and Evera MRI Dual Chamber ICDs
Graph depicting Cobalt XT's Single Chamber's longevity projections against Visia AF and Visia AF MRI Single Chamber

Increased Energy Delivery

MAXIMUM PROGRAMMED ENERGY 40 J

MAXIMUM

DELIVERED

ENERGY<sup>†</sup>

47 J

MAXIMUM

STORED

ENERGY<sup>‡</sup>

47 J

Intrinsic ATP

Intrinsic ATP™ is the only automated and smart ventricular antitachycardia pacing (ATP) algorithm that provides individualized therapy in real time.

In a virtual modeling study, Intrinsic ATP’s termination rate was 22% higher than traditional ATP (burst) with no difference in acceleration rate.7

% of termination 
Graph depicting iATP's 22% increase in termination rate compared to traditional ATP's
White gear icon

Simplified 

Programming 

On/Off

White heart icon

INDIVIDUALIZED

Therapy 

ATP designed
for each VT

White clock icon

Real-time

Response 

If VT is redetected,
iATP automatically
adjusts the next
ATP sequence

REIMAGINED CONNECTIVITY 

BlueSync technology within Cobalt XT enables secure, wireless communication.

CareLink SmartSync interface shown on tablet

Tablet-based CareLink SmartSync™ device manager

Image showing Cobalt XT ICDs and CRT-Ds

Cobalt XT ICDs and CRT-Ds

Image of app and home communicator on white background

MyCareLink Heart™ mobile app or MyCareLink Relay™ Home Communicator

BeConnected service shown on desktop monitor

CareLink network and the BeConnected service

STREAMLINED WORKFLOWS & HEART FAILURE MANAGEMENT 

TriageHF™|| is a simplified, integrated heart failure risk assessment tool that alerts clinicians to clinically relevant changes in a patient’s status that may lead to a heart failure decompensation.

Patient’s risk level is
generated by assessing8:

  • OptiVol™
  • Patient Activity
  • AT/AF Burden
  • Ventricular Rate during AT/AF
  • % Ventricular Pacing
  • Shocks
  • Treated VT/VF
  • Night Ventricular Rate
  • Heart Rate Variability

Yellow arrow pointing right through white calculator icon

Risk score

Risk of a HF hospitalization in the next 30 days9

HIGHHazard Ratio 10x
MEDIUMHazard Ratio 2.1x
LOWNeg Pred Value 99.4%

System features & Exclusive Algorithms

Discover exclusive features and algorithms available in Cobalt XT ICDs and CRT-Ds.

Additional resources 

Related Pages

Medtronic 24-hour support

1-800-505-4636

Medtronic Academy

Find additional feature information along with a variety of educational resources and tools.

Visit Medtronic Academy
*

With AdaptivCRT™ programmed to BiV and LV.

Energy delivered at connector block into a 50 Ω ± 1% load.

Energy stored at charge end on capacitor.

§

From ADVANCE III, using ATP during charging along with NID = 30/40 programming, ATP reduced shocked episodes by 52%.10

||

TriageHF is not an alarm. The TriageHF assessment does not replace heart failure assessments in standard clinical practice. Medical treatment should not be modified remotely based solely on the TriageHF assessment. Interpretation of the TriageHF assessment requires clinical judgement by a medical professional. The TriageHF assessment should be used in conjunction with professional guidelines for patient management decisions.

References

1

Medtronic Claria MRI™ Quad CRT-D SureScan™ and Amplia MRI™ Quad CRT-D SureScan™ Median Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201600236 EN.

2

Medtronic Cobalt™ XT HF Quad MRI SureScan™ Model DTPA2QQ device manual.

3

Medtronic Evera MRI™ XT DR SureScan™ and Evera MRI™ S DR SureScan™ Median Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201600236 EN.

4

Medtronic Cobalt™ XT DR MRI SureScan™ Model DDPC3D4 device manual.

5

Medtronic Visia AF™ VR and Visia AF MRI™ VR SureScan™ Median Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201600236 EN.

6

Medtronic Cobalt™ XT VR MRI SureScan™ Model DVPC3D4 device manual

7

Swenson D, et al. A self-adaptive approach to antitachycardia pacing – a head to head comparison using advanced computational modeling. Poster P6555 presented at ESC Congress 2019; Amsterdam.

8

Medtronic CareLink™ Heart Failure Risk Status Technical Manual M945636A001 A.

9

Cowie MR, Sarkar S, Koehler J, et al. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J. August 2013;34(31):2472-2480.

10

Arenal A, Proclemer A, Kloppe A, et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace. November 2016;18(11):1719-1725.